Aeterna Zentaris Valuation
| AEZSDelisted Stock | USD 6.14 0.08 1.29% |
At this time, the firm appears to be overvalued. Aeterna Zentaris shows a prevailing Real Value of $5.72 per share. The current price of the firm is $6.14. Our model approximates the value of Aeterna Zentaris from analyzing the firm fundamentals such as Shares Owned By Insiders of 1.32 %, return on equity of -0.82, and Current Valuation of 15.15 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Aeterna Zentaris' price fluctuation is very steady at this time. Calculation of the real value of Aeterna Zentaris is based on 3 months time horizon. Increasing Aeterna Zentaris' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Aeterna stock is determined by what a typical buyer is willing to pay for full or partial control of Aeterna Zentaris. Since Aeterna Zentaris is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aeterna Stock. However, Aeterna Zentaris' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.14 | Real 5.72 | Hype 6.14 |
The intrinsic value of Aeterna Zentaris' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aeterna Zentaris' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aeterna Zentaris helps investors to forecast how Aeterna stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aeterna Zentaris more accurately as focusing exclusively on Aeterna Zentaris' fundamentals will not take into account other important factors: Aeterna Zentaris Total Value Analysis
Aeterna Zentaris is presently forecasted to have valuation of 15.15 M with market capitalization of 18.04 M, debt of 277.57 K, and cash on hands of 58.16 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Aeterna Zentaris fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.15 M | 18.04 M | 277.57 K | 58.16 M |
Aeterna Zentaris Investor Information
The company has price-to-book (P/B) ratio of 0.88. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aeterna Zentaris recorded a loss per share of 2.3. The entity last dividend was issued on the 31st of August 2010. The firm had 1:4 split on the 3rd of May 2024. Based on the key indicators related to Aeterna Zentaris' liquidity, profitability, solvency, and operating efficiency, Aeterna Zentaris is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Aeterna Zentaris Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aeterna Zentaris has an asset utilization ratio of 12.44 percent. This implies that the Company is making $0.12 for each dollar of assets. An increasing asset utilization means that Aeterna Zentaris is more efficient with each dollar of assets it utilizes for everyday operations.Aeterna Zentaris Ownership Allocation
The market capitalization of Aeterna Zentaris is $18.04 Million. Almost 93.47 percent of Aeterna Zentaris outstanding shares are held by general public with 1.32 (percent) owned by insiders and only 5.21 % by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Aeterna Zentaris Profitability Analysis
The company reported the previous year's revenue of 4.58 M. Net Loss for the year was (16.86 M) with profit before overhead, payroll, taxes, and interest of 5.17 M.About Aeterna Zentaris Valuation
The delisted stock valuation mechanism determines Aeterna Zentaris' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Aeterna Zentaris based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aeterna Zentaris. We calculate exposure to Aeterna Zentaris's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aeterna Zentaris's related companies.Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina. Aeterna Zentaris is traded on NASDAQ Exchange in the United States.
Aeterna Zentaris Growth Indicators
Investing in growth stocks can be very risky. If the company such as Aeterna Zentaris does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 4.9 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Aeterna Stock
If you are still planning to invest in Aeterna Zentaris check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aeterna Zentaris' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets |